Sign in
CompletedNo phase

Postural Management for Hip Luxation in Quadriplegic Cerebral Palsy

Key facts

Who runs it
Azienda USL Reggio Emilia - IRCCS
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
17 people enrolled
Started
29 Oct 2020
Ended
31 Dec 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • postural management
Record updated
7 May 2026

Who can take part

Age
1 year to 6 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Cerebral palsy spastic or dyskinetic
  • GMFCS 4 or 5
  • MP<41%
  • Informed Consent acquired

Who cannot take part

  • previous reconstructive hip surgery
  • preventive surgery in previous 12 months
  • muscle contracture overcoming defined passive Range Of Motion (ROM)limits
  • anterior hip luxation
  • lumbar scoliosis >20° Cobb

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Cerebral palsy (CP) is the most common motor disability in childhood. Among these, hip luxation represents the most frequent and clinically relevant one, affecting 72% of non-ambulatory CP children. Reconstructive surgical treatment is debated in severe CP children, for whom it is crucial to identify an effective preventive approach. The aim of our study is to verify if keeping a sitting position centering femoral heads is more effective than usual postural management (sitting with the trunk aligned and hips abducted), in preventing hip luxation in quadriplegic CP children. It's a multicenter randomized controlled study (13 sites involved). A total of 102 quadriplegic CP children, aged 1-6 years-old, classified as Gross Motor Function Measure System 4 or 5, will be recruited and randomized to usual or experimental sitting, at least 5 hours a day, for 2 years. The primary outcome will be the degree of luxation, measured by means of the Migration Percentage (MP), on pelvic radiography, at 12 and 24 months. Secondary outcomes will include compliance and Health Related-Quality of Life, using validated tools, hip pain, device cost, MRI lesions, concurrent direct neuromotor treatment, use of standing devices and spasticity treatments (botulinum toxin, per os or intrathecal baclofen, selective dorsal rhizotomy). Experimental sitting is expected to reduce the MP change compared to usual care. It will be of interest to compare compliance, QoL and costs in either groups: aspects affecting the effectiveness. Furthermore to evaluate correlations between MP and spasticity treatments, MRI lesion type, and other clinical features.

The 2 groups in the trial

  • sitting position centering femoral headsTreatment being tested

    sitting position centering femoral heads according to Lespargot diagram

    Treatment: postural management

  • Usual postural managementExisting treatment, for comparison

    sitting with the trunk aligned and hips abducted to facilitate activities of daily living

    Treatment: postural management

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Postural Management to Prevent Hip Luxation in Quadriplegic Cerebral Palsy Children: Comparing Two Approaches in a Randomized Controlled Trial
Publications
Record updated
7 May 2026